Suven Life Sciences Ltd
Next 500 2020
+ 1 More
+ 1 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#458(2020)#432(2019)
#458(2020)#432(2019)
Ranking Trend Fortune Next 500 India
Financial Data 2024
Revenue
40
(INR Cr)
Net Operating Income
12
(INR Cr)
Assets
272
(INR Cr)
Profit
-105
(INR Cr)
Net Worth
270
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 40 43.9% | 28 63.1% | 17 -19.2% | 21 -25.4% | 28 -91.2% | 322 -51.9% | 670 18.0% | 568 6.9% | 531 0.9% | 526 -0.3% | 527 99.4% | 265 25.0% | 212 39.1% | 152 13.8% | 134 -8.6% | 146 - |
| Net Operating Income (INR Cr) | 12 -13.66% | 14 14.36% | 12 -12.17% | 13 -6.45% | 14 -94.96% | 286 -54.31% | 625 15.04% | 544 8.81% | 500 -4.10% | 521 0.00% | 510 97.89% | 258 26.33% | 204 35.78% | 150 16.49% | 129 -7.75% | 140 19.30% |
| Profit (INR Cr) | -105 - | -118 - | -122 - | -72 - | -94 - | -24 - | 124 41.9% | 87 21.4% | 72 -33.9% | 109 -24.6% | 144 367.4% | 31 114.8% | 14 38.1% | 10 48.6% | 7 -1.7% | 7 - |
| Assets (INR Cr) | 272 -28.2% | 379 273.7% | 101 -11.5% | 115 -24.4% | 152 -37.9% | 244 -69.7% | 806 8.7% | 742 8.8% | 682 1.7% | 670 87.8% | 357 30.7% | 273 20.3% | 227 17.4% | 194 15.1% | 168 6.7% | 158 - |
| Net Worth (INR Cr) | 270 -28.1% | 375 290.4% | 96 -11.0% | 108 -24.7% | 143 -40.1% | 239 -68.8% | 767 15.1% | 667 12.1% | 595 6.4% | 559 0.0% | 264 71.2% | 154 21.1% | 128 0.6% | 127 7.3% | 118 3.2% | 114 2.0% |
| Employee Cost (INR Cr) | 19 2.0% | 19 -11.4% | 21 13.4% | 19 6.4% | 17 -52.3% | 36 -40.4% | 61 17.4% | 52 27.4% | 41 12.1% | 37 16.1% | 31 23.9% | 25 11.1% | 23 28.2% | 18 16.2% | 15 0.4% | 15 - |
| Interest Cost (INR Cr) | 0 | 0 | 1 | 1 | 1 | 2 | 5 | 6 | 6 | 5 | 11 | 14 | 10 | 6 | 5 | 7 |
| Cash & Bank Balance (INR Cr) | 164 | 184 | 6 | 47 | 15 | 1 | 28 | 9 | 241 | 280 | 68 | 22 | 3 | 3 | 2 | 1 |
| Total Debt (INR Cr) | 1 | 2 | 3 | 5 | 6 | 3 | 34 | 71 | 83 | 109 | 91 | 117 | 98 | 66 | 50 | 43 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | - | - | - | - | - | - | 18.5% | 15.4% | 13.5% | 20.7% | 27.3% | 11.7% | 6.8% | 6.8% | 5.2% | 4.9% |
| Profit As % Of Assets | - | - | - | - | - | - | 15.3% | 11.8% | 10.5% | 16.2% | 40.4% | 11.3% | 6.3% | 5.4% | 4.2% | 4.5% |
| Profit As % Of Networth | - | - | - | - | - | - | 16.1% | 13.1% | 12.1% | 19.4% | 54.5% | 20.0% | 11.3% | 8.2% | 5.9% | 6.2% |
| Interest Cost to EBITDA % | - | - | - | - | - | - | 2.3% | 4.4% | 5.8% | 3.0% | 4.8% | 25.4% | 42.8% | 45.0% | 36.7% | 58.6% |
| Debt to Equity Ratio | 0.00 | 0.00 | 0.03 | 0.04 | 0.04 | 0.01 | 0.04 | 0.11 | 0.14 | 0.19 | 0.34 | 0.76 | 0.77 | 0.52 | 0.42 | 0.38 |
| RONW | - | - | - | - | - | - | 17.3% | 11.6% | 10.4% | 19.4% | 68.8% | 21.9% | 11.3% | 8.5% | 6.0% | 11.0% |
| ROCE | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -3.6% | 25.9% | 15.3% | 13.0% | 23.3% | 67.7% | 18.5% | 9.1% | 5.2% | 5.3% | 11.0% |